[HTML][HTML] Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements
Purpose Cardiac involvement predicts poor prognosis in light chain (AL) amyloidosis, and
the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-…
the current prognostic classification is based on cardiac biomarkers troponin-T (cTnT) and N-…
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
…, RA Kyle, DR Larson, LJ Melton, CL Colby… - The Lancet, 2010 - thelancet.com
Background Monoclonal gammopathy of undetermined significance (MGUS) is defined by
expression of heavy-chain immunoglobulin (IgH) and is the precursor lesion for 80% of cases …
expression of heavy-chain immunoglobulin (IgH) and is the precursor lesion for 80% of cases …
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
…, JA Katzmann, DR Larson, CL Colby… - Blood, The Journal …, 2010 - ashpublications.org
Immunoglobulin free light chains (FLCs) are the precursors of amyloid fibrils in primary
amyloidosis (AL). We studied the relationship between FLC levels and clinical features in 730 …
amyloidosis (AL). We studied the relationship between FLC levels and clinical features in 730 …
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population
…, RA Kyle, DR Larson, TM Therneau, CL Colby… - Mayo Clinic …, 2012 - Elsevier
Objective To determine whether the free light chain (FLC) assay provides prognostic
information relevant to the general population. Methods After excluding persons with a known …
information relevant to the general population. Methods After excluding persons with a known …
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
…, BJ Foreman, DR Larson, CL Colby… - Blood, The Journal …, 2009 - ashpublications.org
We examined whether monoclonal gammopathy of undetermined significance (MGUS) is
increased in first-degree relatives of multiple myeloma (MM) or MGUS patients. Probands were …
increased in first-degree relatives of multiple myeloma (MM) or MGUS patients. Probands were …
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition
…, LJ Melton III, DR Larson, JT Benson, CL Colby… - Mayo Clinic …, 2012 - Elsevier
Objectives To determine the incidence of monoclonal gammopathy of undetermined significance
(MGUS) in the general population and to estimate the duration of occult MGUS before …
(MGUS) in the general population and to estimate the duration of occult MGUS before …
[HTML][HTML] SNP interaction detection with random forests in high-dimensional genetic data
SJ Winham, CL Colby, RR Freimuth, X Wang… - BMC …, 2012 - Springer
Background Identifying variants associated with complex human traits in high-dimensional
data is a central goal of genome-wide association studies. However, complicated etiologies …
data is a central goal of genome-wide association studies. However, complicated etiologies …
[HTML][HTML] Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Bipolar disorder (BD) has high clinical heterogeneity, frequent psychiatric comorbidities,
and elevated suicide risk. To determine genetic differences between common clinical sub-…
and elevated suicide risk. To determine genetic differences between common clinical sub-…
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
G Bianchi, RA Kyle, CL Colby… - Blood, The Journal …, 2010 - ashpublications.org
Monoclonal gammopathy of undetermined significance (MGUS) is associated with a long-term
risk of progression to multiple myeloma (MM) or related malignancy. To prevent serious …
risk of progression to multiple myeloma (MM) or related malignancy. To prevent serious …
[HTML][HTML] Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry
Multiple myeloma (MM) is two- to three-fold more common in African Americans (AAs) compared
to European Americans (EAs). This striking disparity, one of the highest of any cancer, …
to European Americans (EAs). This striking disparity, one of the highest of any cancer, …